GILEAD SCIENCES, INC. Payments of Stock Issuance Costs
GILEAD SCIENCES, INC. (GILD) reported Payments of Stock Issuance Costs of $4.02 million for the 12-month period ending 2010-12-31, per its 10-K filed 2013-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2013-02-27
- GILEAD SCIENCES, INC. payments of stock issuance costs for fiscal 2010 was $4.02M.
| Period end | Payments of Stock Issuance Costs 12 month |
|---|---|
| 2010-12-31 | $4.02M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |